| 2026-03-03 |
详情>>
股本变动：
变动后总股本1847.31万股
|
| 2026-03-03 |
详情>>
业绩披露：
2025年年报每股收益20.40美元,归母净利润3.67亿美元,同比去年增长1999.08%
|
| 2026-03-03 |
财报披露：
美东时间 2026-03-03 盘后发布财报
|
| 2026-02-20 |
详情>>
内部人交易：
MOOS WALTER H共交易2笔
|
| 2025-11-04 |
详情>>
业绩披露：
2025年三季报(累计)每股收益5.52美元,归母净利润9895.90万美元,同比去年增长3047.55%
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益3.98美元,归母净利润7105.90万美元,同比去年增长865.97%
|
| 2025-05-06 |
详情>>
业绩披露：
2025年一季报每股收益0.64美元,归母净利润1144.60万美元,同比去年增长238.79%
|
| 2025-04-10 |
股东大会：
将于2025-05-22召开股东大会
会议内容 ▼▲
- 1.To elect the two nominees named in this proxy statement, Kamil Ali-Jackson, and Jane Wasman, to the Board of Directors of the Company, to hold office until the Company’s 2028 Annual Meeting of Stockholders.
2.To approve an amendment to our 2018 Equity Incentive Plan, as amended (the “Amended 2018 Plan”), to add an additional 700,000 shares to the number of shares of common stock authorized for issuance under the Amended 2018 Plan.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the accompanying proxy statement.
4.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.
|
| 2025-03-04 |
详情>>
业绩披露：
2022年年报每股收益-3.44美元,归母净利润-5857.3万美元,同比去年增长-226.97%
|
| 2025-03-04 |
详情>>
业绩披露：
2024年年报每股收益0.99美元,归母净利润1748.50万美元,同比去年增长169.69%
|
| 2024-11-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.49美元,归母净利润-2582.8万美元,同比去年增长56.93%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.18美元,归母净利润314.40万美元,同比去年增长112.17%
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益-0.53美元,归母净利润-927.7万美元,同比去年增长53.93%
|
| 2024-06-27 |
复牌提示：
2024-06-26 19:50:00 停牌，复牌日期 2024-06-27 09:00:00
|
| 2024-06-27 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益-0.05美元,归母净利润-824.7万美元,同比去年增长39.07%
|
| 2024-04-10 |
股东大会：
将于2024-05-22召开股东大会
会议内容 ▼▲
- 1.To elect the two nominees named in this proxy statement, Brian L. Kotzin, and Gregg A. Lapointe, to the Board of Directors of the Company, to hold office until the Company’s 2027 Annual Meeting of Stockholders.
2.To approve an amendment to our 2018 Equity Incentive Plan, as amended (the “Amended 2018 Plan”), to add an additional 6,500,000 shares to the number of shares of common stock authorized for issuance under the Amended 2018 Plan.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the accompanying proxy statement.
4.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.
5.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of common stock (without reducing the authorized number of shares of common stock), if and when determined by the Company’s Board of Directors.
6.To approve the adjournment of the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split.
|
| 2024-03-05 |
详情>>
业绩披露：
2023年年报每股收益-0.14美元,归母净利润-2509.1万美元,同比去年增长57.16%
|
| 2023-04-14 |
股东大会：
将于2023-05-25召开股东大会
会议内容 ▼▲
- 1.To elect the three nominees named in this proxy statement, Alison L. Hannah, Walter H. Moos and Raul R. Rodriguez, to the Board of Directors of the Company, to hold office until the Company’s 2026 Annual Meeting of Stockholders.
2.To approve an amendment to our 2018 Equity Incentive Plan, as amended (the “Amended 2018 Plan”), to add an additional 4,000,000 shares to the number of shares of common stock authorized for issuance under the Amended 2018 Plan.
3.To approve, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company’s named executive officers.
4.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the accompanying proxy statement.
5.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2023.
6.To conduct any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2022-04-05 |
股东大会：
将于2022-05-19召开股东大会
会议内容 ▼▲
- 1.To elect the two nominees named in this proxy statement, Kamil Ali-Jackson and Jane Wasman, to the Board of Directors of the Company, to hold office until the Company’s 2025 Annual Meeting of Stockholders.
2.To approve an amendment to our 2018 Equity Incentive Plan, as amended (the “Amended 2018 Plan”), to add an additional 5,000,000 shares to the number of shares of common stock authorized for issuance under the Amended 2018 Plan.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the accompanying proxy statement.
4.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2022.
5.To conduct any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-06 |
股东大会：
将于2021-05-18召开股东大会
会议内容 ▼▲
- 1.To elect the nominees, Gregg A. Lapointe, Brian L. Kotzin and Gary A. Lyons, to the Board of Directors of the Company to hold office until the Company’s 2024 Annual Meeting of Stockholders.
2.To approve an amendment to our 2018 Equity Incentive Plan, as amended (the “Amended 2018 Plan”), to, among other items, (i) add an additional 825,000 shares to the number of shares of common stock authorized for issuance under the Amended 2018 Plan, (ii) remove the automatic nondiscretionary option grants to non-employee directors and (iii) add an overall limit to non-employee director compensation.
3.To approve an amendment to our 2000 Employee Stock Purchase Plan, as amended (the “Amended 2000 ESPP”), to, among other things, add an additional 5,500,000 shares to the number of shares of common stock authorized for issuance under the Amended 2000 ESPP.
4.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the accompanying proxy statement.
5.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2021.
6.To conduct any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2020-04-01 |
股东大会：
将于2020-05-14召开股东大会
会议内容 ▼▲
- 1.To elect the nominees, Walter H. Moos and Raul R. Rodriguez to the Board of Directors of the Company (the "Board") to hold office until the 2023 Annual Meeting of Stockholders
2.To approve our 2018 Equity Incentive Plan, as amended (the "Amended 2018 Plan"), to, among other items, (i) add an additional 2,800,000 shares to the number of shares of common stock authorized for issuance under the Amended 2018 Plan, and (ii) change the fungible share counting ratio so that the share reserve will be reduced or increased by 1.44 shares for each share of common stock issued pursuant to, or returning from, a Full Value Award (as defined below).
3.To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in this proxy statement.
4.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2020.
5.To conduct any other business properly brought before the meeting or any adjournment or postponement of the meeting.
|
| 2019-04-09 |
股东大会：
将于2019-05-22召开股东大会
会议内容 ▼▲
- 1.To elect the nominees, Bradford S. Goodwin, Keith A. Katkin, and Jane Wasman to the Board of Directors of the Company (the "Board") to hold office until the 2022 Annual Meeting of Stockholders.
2.To approve the Company's 2018 Equity Incentive Plan, as amended (the "2018 Plan") to increase the aggregate number of shares of common stock authorized for issuance under the 2018 Plan by 4,000,000 shares.
3.To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in this proxy statement.
4.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2019.
5.To conduct any other business properly brought before the meeting or any adjournment or postponement of the meeting.
|
| 2018-04-04 |
股东大会：
将于2018-05-16召开股东大会
会议内容 ▼▲
- 1.To elect the nominees, Gregg A. Lapointe, Brian L. Kotzin and Gary A. Lyons to the Board of Directors of the Company (the "Board") to hold office until the 2021 Annual Meeting of Stockholders.
2.To approve the Company's 2018 Equity Incentive Plan (the "2018 Plan").
3.To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in this proxy statement.
4.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2018.
5.To approve an amendment to the Certificate of Incorporation of the Company to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000 shares.
6.To conduct any other business properly brought before the meeting or any adjournment or postponement of the meeting.
|
| 2017-03-29 |
股东大会：
将于2017-05-11召开股东大会
会议内容 ▼▲
- 1.To elect the nominees, Walter H. Moos and Raul R. Rodriguez to the Board of Directors of the Company (the “Board”) to hold office until the 2020 Annual Meeting of Stockholders.
2.To approve the Company’s 2011 Equity Incentive Plan, as amended (the “2011 Plan”) to (i) increase the aggregate number of shares of common stock authorized for issuance under the 2011 Plan by 4,500,000 shares and (ii) add a definitive term of ten years to any appreciation rights granted.
3.To approve the Company’s 2000 Non-Employee Directors’ Stock Option Plan, as amended (the “Directors’ Plan”) to increase the aggregate number of shares of common stock authorized for issuance under the Directors’ Plan by 800,000 shares.
4.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
5.To approve, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company’s named executive officers.
6.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2017.
7.To conduct any other business properly brought before the meeting or any adjournment or postponement of the meeting.
|
| 2016-03-28 |
股东大会：
将于2016-05-10召开股东大会
会议内容 ▼▲
- 1.To elect the nominees, Peter S. Ringrose, Ph.D., Bradford S. Goodwin and Keith A. Katkin, to the Board of Directors of the Company (the “Board”) to hold office until the 2019 Annual Meeting of Stockholders.
2.To approve the Company’s 2011 Equity Incentive Plan, as amended (the "2011 Plan") to increase the aggregate number of shares of common stock authorized for issuance under the 2011 Plan by 2,150,000 shares.
3.To approve the Company's 2000 Non-Employee Directors' Stock Option Plan, as amended (the "Directors' Plan") to increase the aggregate number of shares of common stock authorized for issuance under the Directors' Plan by 350,000 shares.
4.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
5.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2016.
6.To conduct any other business properly brought before the meeting or any adjournment or postponement of the meeting.
|